Express Delivery
All orders are shipped with Econt
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
hGH Fragment 176-191 is a synthetic peptide, representing a modified fragment (amino acids 176-191) from the C-terminal portion of human growth hormone (hGH). It was created to isolate the lipolytic (fat-breaking) properties of GH without activating its other physiological effects. In scientific literature, hGH Frag has been studied as a potential regulator of lipolysis and metabolic balance.
Unlike full-length growth hormone, HGH Frag 176-191 does not show significant activity on IGF-1 levels and does not stimulate tissue growth. Instead, according to scientific research, the peptide has been associated with stimulating lipolysis and inhibiting lipogenesis, making it an interesting model for studying metabolic processes related to fat metabolism.
In scientific literature, HGH Frag 176-191 has been studied in relation to:
Stimulation of lipolysis - promotes the breakdown of fatty acids in adipocytes
Inhibition of lipogenesis - suppresses the accumulation of new fat cells
Regulation of body weight - investigated as a potential metabolic modulator
Maintenance of lean muscle mass - without anabolic effects typical of GH
Reduction of visceral fat - in obesity models
Improvement of insulin sensitivity - observed in some preclinical studies
In scientific literature, cited doses range between 250-500 μg daily, administered subcutaneously, often divided into 1-2 applications. The peptide is typically used in short-term research cycles focused on lipolytic mechanisms. HGH frag. is the most hydrophobic peptide, its solubility is lower and requires dissolution with the entire amount of solution.
With 5 mg + 3 ml bacteriostatic water:
Concentration = 1.67 mg/ml → 0.06 ml = 100 μg
Example values:
0.06 ml = 100 μg
0.12 ml = 200 μg
0.18 ml = 300 μg
0.24 ml = 400 μg
HGH Frag 176-191 has been studied primarily in preclinical models and limited clinical trials. Key scientific observations include:
Increased lipolysis in adipocyte cultures and in vivo models
Reduction of total and visceral adipose tissue without changes in IGF-1 levels
Lack of effect on glucose homeostasis at low doses
Absence of influence on organ and tissue growth
Improved lipid metabolism and energy efficiency in some experimental models
HGH Fragment 176-191 is listed by WADA as a controlled substance and is not permitted for use by professional athletes. In a research context, the peptide is used to study lipolytic mechanisms and energy metabolism in various models of metabolic syndrome, obesity, and insulin resistance.
Model for studying mechanisms of fat reduction
Research on insulin sensitivity and lipid metabolism
Possible synergy with other peptides regulating energy balance
In scientific literature, HGH Frag 176-191 is considered well-tolerated. Observed reactions are usually mild and transient:
Redness or discomfort at the injection site
Mild fatigue or drowsiness
Headache at higher doses
There are no published data on serious side effects at research doses. Effects are dose-dependent and temporary.
The information is based on scientific publications and serves for educational purposes only. It is not intended for the diagnosis, treatment, or prevention of diseases.